Actively Recruiting
Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects
Led by Aura Biosciences · Updated on 2026-02-19
15
Participants Needed
1
Research Sites
143 weeks
Total Duration
On this page
Sponsors
A
Aura Biosciences
Lead Sponsor
V
Vitaccess Ltd
Collaborating Sponsor
AI-Summary
What this Trial Is About
To assess subject-centric real-world evidence of QoL outcomes in subjects enrolled in the global Phase 3 AU-011-301 clinical trial.
CONDITIONS
Official Title
Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Have enrolled in the Aura-sponsored clinical trial AU-011-301.
- Access to a connected device (i.e., smartphone, laptop, or tablet)
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Eye Research Australia
East Melbourne, Victoria, Australia, 3002
Actively Recruiting
Research Team
M
Medical Monitor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here